$OXFD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oxford Immunotec Global PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oxford Immunotec Global PLC. Get notifications about new insider transactions in Oxford Immunotec Global PLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.27 | 1,529 | 21,819 | 2,277,078 | 2.3 M to 2.3 M (-0.07 %) |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.25 | 6,430 | 91,628 | 2,278,607 | 2.3 M to 2.3 M (-0.28 %) |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.27 | 25,168 | 359,147 | 2,285,037 | 2.3 M to 2.3 M (-1.09 %) |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.17 | 7,457 | 105,666 | 7,457 | |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | A | 14.17 | 7,457 | 105,666 | 7,457 | |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | A | 14.17 | 7,457 | 105,666 | 7,457 | |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | Spotts Stephen L | Director | Option Exercise | A | 14.17 | 7,457 | 105,666 | 7,457 | |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 14.17 | 7,457 | 105,666 | 7,457 | |
Jun 11 2015 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | VP & General Counse ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Jun 10 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.32 | 8,987 | 128,694 | 2,310,205 | 2.3 M to 2.3 M (-0.39 %) |
Jun 10 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.26 | 13,000 | 185,380 | 2,319,192 | 2.3 M to 2.3 M (-0.56 %) |
Jun 10 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.25 | 2,662 | 37,934 | 2,332,192 | 2.3 M to 2.3 M (-0.11 %) |
Jun 03 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.32 | 10,450 | 149,644 | 2,334,854 | 2.3 M to 2.3 M (-0.45 %) |
Jun 03 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.25 | 11,014 | 156,950 | 2,345,304 | 2.4 M to 2.3 M (-0.47 %) |
Jun 03 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.29 | 15,010 | 214,493 | 2,356,318 | 2.4 M to 2.4 M (-0.63 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.00 | 100 | 1,400 | 45,174 | 45.3 K to 45.2 K (-0.22 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.01 | 200 | 2,801 | 45,274 | 45.5 K to 45.3 K (-0.44 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.01 | 100 | 1,401 | 45,474 | 45.6 K to 45.5 K (-0.22 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.02 | 100 | 1,402 | 45,574 | 45.7 K to 45.6 K (-0.22 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.03 | 100 | 1,403 | 45,674 | 45.8 K to 45.7 K (-0.22 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.04 | 210 | 2,948 | 45,774 | 46 K to 45.8 K (-0.46 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.05 | 390 | 5,480 | 45,984 | 46.4 K to 46 K (-0.84 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.07 | 100 | 1,407 | 46,374 | 46.5 K to 46.4 K (-0.22 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.12 | 100 | 1,412 | 46,474 | 46.6 K to 46.5 K (-0.21 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.21 | 200 | 2,842 | 46,574 | 46.8 K to 46.6 K (-0.43 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.22 | 300 | 4,266 | 46,774 | 47.1 K to 46.8 K (-0.64 %) |
Jun 02 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.23 | 1,100 | 15,653 | 47,074 | 48.2 K to 47.1 K (-2.28 %) |
Mar 24 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.44 | 26,300 | 379,772 | 2,371,328 | 2.4 M to 2.4 M (-1.10 %) |
Mar 24 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.53 | 27,115 | 393,981 | 2,397,628 | 2.4 M to 2.4 M (-1.12 %) |
Mar 19 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.61 | 50,012 | 730,675 | 2,424,743 | 2.5 M to 2.4 M (-2.02 %) |
Mar 19 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.68 | 25,000 | 367,000 | 2,474,755 | 2.5 M to 2.5 M (-1.00 %) |
Mar 19 2015 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 14.67 | 79,307 | 1,163,434 | 2,499,755 | 2.6 M to 2.5 M (-3.08 %) |
Jan 21 2015 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | A | 14.57 | 18,513 | 269,734 | 18,513 | |
Jan 21 2015 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | A | 14.57 | 17,644 | 257,073 | 17,644 | |
Jan 21 2015 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 14.57 | 51,403 | 748,942 | 51,403 | |
Jan 21 2015 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Option Exercise | A | 14.57 | 16,747 | 244,004 | 16,747 | |
Jan 21 2015 | OXFD | Oxford Immunotec G ... | Keiley Elizabeth M | VP & General Counse ... | Option Exercise | A | 14.57 | 9,000 | 131,130 | 9,000 | |
Jan 16 2015 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Sell | S | 14.00 | 3,000 | 42,000 | 48,174 | 51.2 K to 48.2 K (-5.86 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 11.87 | 340 | 4,036 | 3,650 | 4 K to 3.7 K (-8.52 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 11.88 | 1,000 | 11,880 | 3,990 | 5 K to 4 K (-20.04 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 11.89 | 100 | 1,189 | 4,990 | 5.1 K to 5 K (-1.96 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 11.90 | 400 | 4,760 | 5,090 | 5.5 K to 5.1 K (-7.29 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 11.91 | 400 | 4,764 | 5,490 | 5.9 K to 5.5 K (-6.79 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 12.20 | 385 | 4,697 | 5,890 | 6.3 K to 5.9 K (-6.14 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 12.20 | 2,275 | 27,755 | 6,275 | 8.6 K to 6.3 K (-26.61 %) |
Dec 08 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Sell | S | 12.40 | 100 | 1,240 | 8,550 | 8.7 K to 8.6 K (-1.16 %) |
Dec 05 2014 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 13.02 | 14,914 | 194,180 | 14,914 | |
Dec 05 2014 | OXFD | Oxford Immunotec G ... | TOBIN JAMES R | Director | Option Exercise | A | 13.02 | 7,457 | 97,090 | 7,457 | |
Jul 11 2014 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Gift | G | 0.00 | 2,500 | 0 | 51,174 | 53.7 K to 51.2 K (-4.66 %) |
Jun 16 2014 | OXFD | Oxford Immunotec G ... | SANDBERG RICHARD A | Director | Option Exercise | A | 16.86 | 7,457 | 125,725 | 7,457 | |
Jun 16 2014 | OXFD | Oxford Immunotec G ... | Spotts Stephen L | Director | Option Exercise | A | 16.86 | 7,457 | 125,725 | 7,457 | |
Jun 16 2014 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 16.86 | 7,457 | 125,725 | 7,457 | |
Jun 16 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | A | 16.86 | 14,914 | 251,450 | 14,914 | |
Jun 16 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | Director | Option Exercise | A | 16.86 | 7,457 | 125,725 | 7,457 | |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Option Exercise | A | 22.99 | 36,520 | 839,595 | 36,520 | |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Schroeder Jeff R. | Chief Commercial Of ... | Grant | A | 0.00 | 36,520 | 0 | 36,520 | 0 to 36.5 K |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Option Exercise | A | 22.99 | 36,520 | 839,595 | 36,520 | |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Edwardson Peter | Chief Operations Of ... | Grant | A | 0.00 | 36,520 | 0 | 36,520 | 0 to 36.5 K |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Option Exercise | A | 22.99 | 28,720 | 660,273 | 28,720 | |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Altieri Richard M. | Chief Financial Off ... | Grant | A | 0.00 | 28,720 | 0 | 28,720 | 0 to 28.7 K |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 22.99 | 75,440 | 1,734,366 | 75,440 | |
Mar 05 2014 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 75,440 | 0 | 431,181 | 355.7 K to 431.2 K (+21.21 %) |
Jan 24 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | VP and General Coun ... | Option Exercise | M | 0.09 | 149 | 13 | 0 | |
Jan 24 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | VP and General Coun ... | Option Exercise | M | 0.09 | 8,501 | 765 | 0 | |
Jan 24 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | VP and General Coun ... | Buy | M | 0.09 | 149 | 13 | 8,650 | 8.5 K to 8.7 K (+1.75 %) |
Jan 24 2014 | OXFD | Oxford Immunotec G ... | RANDALL PATRICIA | VP and General Coun ... | Buy | M | 0.09 | 8,501 | 765 | 8,501 | 0 to 8.5 K |
Nov 26 2013 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 15.40 | 14,914 | 229,676 | 14,914 | |
Nov 26 2013 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 15.40 | 7,457 | 114,838 | 7,457 | |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 203,439 | 0 | 0 | |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 553,859 | 0 | 0 | |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,239,308 | 0 | 0 | |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 582,456 | 0 | 0 | |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 203,439 | 0 | 2,579,062 | 2.4 M to 2.6 M (+8.56 %) |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 553,859 | 0 | 2,375,623 | 1.8 M to 2.4 M (+30.40 %) |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 1,239,308 | 0 | 1,821,764 | 582.5 K to 1.8 M (+212.77 %) |
Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 582,456 | 0 | 582,456 | 0 to 582.5 K |